An Anti-tissue Factor Pathway Inhibitor Antibody Increases Tissue Factor Activity in Extracellular Vesicles Isolated from Human Plasma
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Recent Advances in Pathogenesis and Anticoagulation Treatment of Sepsis-Induced Coagulopathy.
Man C, An Y, Wang G, Mao E, Ma L J Inflamm Res. 2025; 18():737-750.
PMID: 39845020 PMC: 11752821. DOI: 10.2147/JIR.S495223.
References
1.
Maroney S, Haberichter S, Friese P, Collins M, Ferrel J, Dale G
. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood. 2006; 109(5):1931-7.
PMC: 1801047.
DOI: 10.1182/blood-2006-07-037283.
View
2.
Tesselaar M, Romijn F, Van der Linden I, Prins F, Bertina R, Osanto S
. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost. 2006; 5(3):520-7.
DOI: 10.1111/j.1538-7836.2007.02369.x.
View
3.
Hisada Y, Mackman N
. Measurement of tissue factor activity in extracellular vesicles from human plasma samples. Res Pract Thromb Haemost. 2019; 3(1):44-48.
PMC: 6332748.
DOI: 10.1002/rth2.12165.
View
4.
Langer F, Spath B, Haubold K, Holstein K, Marx G, Wierecky J
. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Ann Hematol. 2008; 87(6):451-7.
DOI: 10.1007/s00277-008-0446-3.
View
5.
Vallier L, Bouriche T, Bonifay A, Judicone C, Bez J, Franco C
. Increasing the sensitivity of the human microvesicle tissue factor activity assay. Thromb Res. 2019; 182:64-74.
PMC: 6825876.
DOI: 10.1016/j.thromres.2019.07.011.
View